The OptiMA protocol in children with wasting and stunting - Authors' reply
- PMID: 35714646
- DOI: 10.1016/S2214-109X(22)00245-5
The OptiMA protocol in children with wasting and stunting - Authors' reply
Conflict of interest statement
KP serves on the Social Purposes Advisory Commission of Nutriset, a main producer of lipid-based nutrient supplement products. All other authors declare no competing interests.
Comment on
-
Simplifying and optimising the management of uncomplicated acute malnutrition in children aged 6-59 months in the Democratic Republic of the Congo (OptiMA-DRC): a non-inferiority, randomised controlled trial.Lancet Glob Health. 2022 Apr;10(4):e510-e520. doi: 10.1016/S2214-109X(22)00041-9. Lancet Glob Health. 2022. PMID: 35303461 Clinical Trial.
-
The OptiMA protocol in children with wasting and stunting.Lancet Glob Health. 2022 Jul;10(7):e957. doi: 10.1016/S2214-109X(22)00247-9. Lancet Glob Health. 2022. PMID: 35714645 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
